Therapy Areas: AIDS & HIV
20 June 2024 - Biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) on Thursday released topline results from an interim analysis of a Phase 3 trial indicating that the company's twice-yea...
3 April 2024 - Biotechnology company Oxford BioDynamics, Plc (AIM: OBD) announced on Wednesday that clinical validation of its EpiSwitch Prostate Screening (PSE) test has been completed at its newly c...
28 February 2024 - Micron Biomedical, a US-based life science company, announced on Tuesday that it has named global public health pioneer Dr Seth Berkley as scientific advisor to the CEO.In the new r...
6 February 2024 - Biopharmaceutical company GSK plc (LSE/NYSE: GSK) said on Tuesday that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted ...
29 January 2024 - Biopharmaceutical company Takeda (TSE:4502) (NYSE:TAK) announced on Monday that HyQvia [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] has been approved i...
23 January 2024 - Allurion Technologies Inc (NYSE: ALUR), a company focussed on ending obesity, announced on Tuesday that Somerset NHS Foundation Trust (FT) has pioneers the use of the company's ...